The cases of cancers are increasing worldwide. As per the World Health Organisation, around 10 million mortalities and more than 19 million new cases of cancer were registered in 2020 all across the world. Due to this, liquid biopsy market is gaining recognition for tumour analysing. Many cancer patients can be cured using liquid biopsy in the early diagnosis/early stages. Therefore, initiatives to implement and develop liquid biopsy have been introduced by the government globally.